European Journal of Clinical Pharmacology

Papers
(The TQCC of European Journal of Clinical Pharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Therapeutic drug monitoring of oral targeted antineoplastic drugs108
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies75
What about COVID-19 and arachidonic acid pathway?57
The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-257
Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review44
Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review43
Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis39
Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects39
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dem33
Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials32
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK931
Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review28
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis28
Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials26
Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?25
Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review25
Drug prescriptions in nursing home residents: an Italian multicenter observational study25
Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-1924
Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district24
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review23
Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies22
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews21
Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial21
The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials21
Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis20
Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients20
A real or apparent decrease in glomerular filtration rate in patients using olaparib?20
Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients19
Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis19
Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis18
Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity17
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication17
Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients17
Second-generation antipsychotic use during pregnancy and risk of congenital malformations16
Iron chelation may harm patients with COVID-1916
Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists15
Potentially inappropriate medication in older psychiatric patients15
Safety profile of COVID-19 drugs in a real clinical setting15
Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study15
REview of potentially inappropriate MEDIcation pr[e]scribing in Seniors (REMEDI[e]S): French implicit and explicit criteria15
Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study15
Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis14
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology14
Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients14
Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis14
Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low14
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis14
Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage13
Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources13
Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach—an Indian experience13
Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge13
Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study13
External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients13
Safety of azithromycin in pediatrics: a systematic review and meta-analysis13
A drug–drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers12
Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects12
Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma12
Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis12
Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin12
Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysis12
Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials12
Aspirin in people with dementia, long-term benefits, and harms: a systematic review12
Individual factors increasing complexity of drug treatment—a narrative review12
Interventions to optimize prescribed medicines and reduce their misuse in chronic non-malignant pain: a systematic review12
Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies11
Proton pump inhibitor use: systematic review of global trends and practices11
Tocilizumab in transplantation11
Adjuvant use of melatonin for relieving symptoms of painful diabetic neuropathy: results of a randomized, double-blinded, controlled trial11
Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis11
The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis11
The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany11
The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis11
Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses11
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials11
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies11
Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia11
Reply: Iron chelation may harm patients with COVID-1910
Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–201810
Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework10
Cinemeducation in clinical pharmacology: using cinema to help students learn about pharmacovigilance and adverse drug reactions10
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis10
Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin10
Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department10
Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-1910
Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients10
Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme10
Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride10
The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot study10
Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany10
Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?10
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study10
Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis10
What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics10
An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants10
Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation9
Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal9
Direct oral anticoagulant safety during breastfeeding: a narrative review9
Drug utilisation in neonatal units in England and Wales: a national cohort study9
Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study9
Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis9
Pharmaceuticals and Environment: a web-based decision support for considering environmental aspects of medicines in use9
Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study9
Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool9
External evaluation of published population pharmacokinetic models of polymyxin B9
Daridorexant for the treatment of insomnia disorder: findings and implications9
Prediction of the exposure to a 400-mg daily dose of efavirenz in pregnancy: is this dose adequate in extensive metabolisers of CYP2B6?9
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use9
Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study9
Serum concentrations of antidepressants, antipsychotics, and antiepileptics over the bariatric surgery procedure9
Uptake of biosimilar trastuzumab in Denmark compared with other European countries: a comparative study and discussion of factors influencing implementation and uptake of biosimilars9
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study9
Evaluation of drug-drug interactions of pemigatinib in healthy participants9
Estimation of the area under concentration-time curve of polymyxin B based on limited sampling concentrations in Chinese patients with severe pneumonia9
Incidence risk of PD-1/PD-L1–related pneumonia and diarrhea in non-small cell lung cancer (NSCLC) patients: a systematic review and meta-analysis of randomized controlled trials8
Model-based simulation to support the extended dosing regimens of atezolizumab8
Influence of formulation and route of administration on ketamine’s safety and tolerability: systematic review8
Patients’ experiences on adverse drug reactions reporting: a qualitative study8
Doctor’s aptitude for switching from innovator etanercept to biosimilar etanercept in inflammatory rheumatic diseases: experience from a single French rheumatology tertiary care center8
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range8
Different interventions for preventing postoperative catheter-related bladder discomfort: a systematic review and meta-analysis8
Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance8
Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials8
Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-198
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice8
Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis8
Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study8
Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes8
A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management8
Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions8
Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis8
Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study8
Non-steroidal anti-inflammatory drug-associated acute kidney injury: does short-term NSAID use pose a risk in hospitalized patients?8
Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®8
The comparative impact among different intensive statins and combination therapies with niacin/ezetimibe on carotid intima-media thickness: a systematic review, traditional meta-analysis, and network 8
Feasibility study and evaluation of expert opinion on the semi-automated meta-analysis and the conventional meta-analysis7
Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany7
Comparing the clinical outcomes across different sodium/glucose cotransporter 2 (SGLT2) inhibitors in heart failure patients: a systematic review and network meta-analysis of randomized controlled tri7
Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis7
Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industry7
Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models7
The effects of trazodone on human cognition: a systematic review7
Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus7
Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review7
Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review7
Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model7
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study7
Paracetamol overdose in the newborn and infant: a life-threatening event7
DRESS characteristics according to the causative medication7
Impact of concomitant acid suppressive therapy on pazopanib efficacy and dose reductions in patients with metastatic renal cell carcinoma7
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies7
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review7
Effect of GLP-1R rs2254336 and rs3765467 polymorphisms on gastrointestinal adverse reactions in type 2 diabetes patients treated with liraglutide7
Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data7
Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose7
Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with 7
Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria7
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects7
Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review7
Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission7
Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study7
Aqueous humour concentrations after topical apPlication of combinEd levofloxacin-dexamethasone eye dRops and of its single components: a randoMised, assEssor-blinded, parallel-group study in patients 6
Single dose epidural hydromorphone in labour pain: maternal pharmacokinetics and neonatal exposure6
Use of over-the-counter laxatives by community-dwelling adults to treat and prevent constipation: a national cross-sectional study6
Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen6
Borrowing external information to improve Bayesian confidence propagation neural network6
First-in-human dose: current status review for better future perspectives6
Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clin6
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib6
Paradoxical adverse drug reactions: descriptive analysis of French reports6
Efficacy and safety of corticosteroid therapy in patients with cardiac arrest: a systematic review of randomised controlled trials6
The impact of acetylsalicylic acid dosed at bedtime on circadian rhythms of blood pressure in the high-risk group of cardiovascular patients—a randomized, controlled trial6
Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia6
CYP450 polymorphisms and clinical pharmacogenetics of ibuprofen after lower third molar extraction6
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial6
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ9-tetrahydrocannabinol: a pilot study6
Potentially inappropriate medication use and the hospitalization rate among Thai elderly patients: a retrospective cohort study6
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice6
Dasiglucagon: an effective medicine for severe hypoglycemia6
Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia6
The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose–corrected trough concentration in the early period after liver transplantation6
Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients6
The European Prescribing Exam: assessing whether European medical students can prescribe rationally and safely6
Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation6
Investigation of pharmacokinetic and clinical outcomes of various meropenem regimens in patients with ventilator-associated pneumonia and augmented renal clearance6
Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in su6
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project6
Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis6
Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis6
Serum 4β-hydroxycholesterol increases during fluconazole treatment6
A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues6
Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms6
Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study6
Adverse drug reactions in infants, children and adolescents exposed to antidepressants: a French pharmacovigilance study6
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy6
Drug exposure for PDA closure in France: a prospective, cohort-based, analysis6
Physiologically based pharmacokinetic combined BTK occupancy modeling for optimal dosing regimen prediction of acalabrutinib in patients alone, with different CYP3A4 variants, co-administered with CYP6
Evaluating the safety and efficacy of daprodustat for anemia of chronic kidney disease: a meta-analysis of randomized clinical trials6
Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data6
Waivers of informed consent in research with competent participants and the Declaration of Helsinki5
The impact of health literacy on beliefs about medication in a Dutch medication-using population5
CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients5
Tacrolimus monitoring parameters are not associated with acute cellular rejection following lung transplantation5
Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment5
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases5
Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and n5
Dexmedetomidine for prevention of propofol injection pain upon induction of anesthesia: a meta-analysis5
Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population5
Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations—an observational study using blood samples from 1223 patients5
Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis5
A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients5
EurOP2E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers5
COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed5
The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method5
A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study5
Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus5
Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials5
Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database5
Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease5
Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis5
Drug-drug interactions and inappropriate medicines impact on glycemic control and kidney function in older adults with diabetes-attending specialty care institution5
Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease5
Factors affecting high-grade hepatotoxicity of tyrosine kinase inhibitors in cancer patients: a multi-center observational study5
Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis5
Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney disease5
Psychotropic drug use among older people with major neurocognitive disorder: a cross-sectional study based on Swedish national registries5
Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration5
Remdesivir-induced symmetrical drug–related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature5
Drug-related deaths among inpatients: a meta-analysis5
Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition5
Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review5
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype5
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials5
Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study5
Prolonged infusion of linezolid is associated with improved pharmacokinetic/pharmacodynamic (PK/PD) profiles in patients with external ventricular drains5
Prescription analgesia and adjuvant use by pain severity at admission among nursing home residents with non-malignant pain5
Exploring heterogeneities of cardiovascular efficacy and effectiveness of SGLT2 inhibitors in patients with type 2 diabetes: an umbrella review of evidence from randomized clinical trials versus real-5
Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations5
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib5
Post-market utilization patterns of Alzheimer’s disease treatments in South Korea: comparison with countries with universal health coverage5
Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials5
The implementation of health technology assessment principles in public decisions concerning orphan drugs5
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib5
Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults5
Metabolic diversity as a reason for unsuccessful detoxification from benzodiazepines: the rationale for serum BZD concentration monitoring5
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database5
Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD)5
Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability5
0.054327964782715